David A Ramsay

EVP, PRESIDENT, DRUG DELIVERY; Interim CFO · 2 filings · Latest: Jun 30, 2026

HALOZYME THERAPEUTICS, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
HALO	David A Ramsay	EVP, PRESIDENT, DRUG DELIVERY	Jun 30, 2026	Option Exercise	$0.00	10,000	—	10,000	Jul 2 8:45 PM
SVRA	RAMSAY DAVID A	—	Dec 18, 2025	Proposed Sale	$6.11	20,000	$122.2K	—	Dec 18 4:17 PM